Medical Developments International Limited (MVP) Stock Statistics & Valuation Metrics

Medical Developments International Limited has a market cap or net worth of AU$50.70M. The enterprise value is AU$26.09.

Medical Developments International Limited has 112,658,325 shares outstanding. The number of shares has decreased by -2.65% in one year.

Medical Developments International Limited’s return on equity (ROE) is 0.01 and return on invested capital (ROIC) is 1.68%.

The current PE Ratio of Medical Developments International Limited is 82.1. Medical Developments International Limited’s PEG ratio is 0.12.

In the last 12 months, Medical Developments International Limited had revenue of 42.57M and earned 626.00K in profits. Earnings per share was <0.01.

In the last 12 months, operating cash flow was 5.75M and capital expenditures -481.00K, giving a free cash flow of 5.27M billion.

Medical Developments International Limited pays an annual dividend of AU$0.019, resulting in a dividend yield of ―

Medical Developments International Limited upcoming earnings date is Feb 25, 2027, TBA (Confirmed).

Medical Developments International Limited as a current ratio of 5.77, with Debt / Equity ratio of 2.99%

In the past 12 months, Medical Developments International Limited has paid -122.00K in taxes.

Medical Developments International Limited EV to EBITDA ratio is 8.50, with an EV/FCF ratio of 6.04.

Medical Developments International Limited has AU$21.37M in cash and marketable securities with AU$1.67M in debt, giving a net cash position of AU$19.70M billion.

Gross margin is 28.15%, with operating margin of 2.48%, and net profit margin of 1.47%.

The average price target for Medical Developments International Limited is AU$1.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy